pSivida Corp’s Eye Therapy Meets Late-Stage Goal

Reuters -- Drug delivery company pSivida Corp said two late-stage trials on its experimental ophthalmic therapy Iluvien met their main goal, sending its shares up 70 percent in pre-market trade.